首页> 外文期刊>Modern Pathology >Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR)
【24h】

Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR)

机译:报告尿路癌癌 - 活检和经尿道切除标本的数据集:来自癌症报告国际合作的建议(ICCR)

获取原文
       

摘要

The International Collaboration on Cancer Reporting (ICCR) is an alliance of major pathology organisations in Australasia, Canada, Europe, United Kingdom, and United States of America that develops internationally standardised, evidence-based datasets for the pathology reporting of cancer specimens. This dataset was developed by a multidisciplinary panel of international experts based on previously published ICCR guidelines for the production of cancer datasets. It is composed of Required (core) and Recommended (noncore) elements identified on the basis of literature review and expert consensus. The document also includes an explanatory commentary explaining the rationale behind the categorization of individual data items and provides guidance on how these should be collected and reported. The dataset includes nine required and six recommended elements for the reporting of cancers of the urinary tract in biopsy and transurethral resection (TUR) specimens. The required elements include specimen site, operative procedure, histological tumor type, subtype/variant of urothelial carcinoma, tumor grade, extent of invasion, status of muscularis propria, noninvasive carcinoma, and lymphovascular invasion (LVI). The recommended elements include clinical information, block identification key, extent of T1 disease, associated epithelial lesions, coexistent pathology, and ancillary studies. The dataset provides a structured template for globally harmonized collection of pathology data required for management of patients diagnosed with cancer of the urinary tract in biopsy and TUR specimens. It is expected that this will facilitate international collaboration, reduce duplication of effort in updating current national/institutional datasets, and be particularly useful for countries that have not developed their own datasets.
机译:国际癌症报告(ICCR)的国际合作是澳大利亚,加拿大,欧洲,英国和美利坚合众国的主要病理组织联盟,该组织开发了用于癌症标本的病理报告的国际标准化,基于证据的数据集。该数据集是由一个基于以前公布的ICCR的癌症数据集的ICCR指南开发的国际专家组织开发的。它由必要(核心)和建议(非核)的元素组成,根据文献审查和专家共识确定。该文件还包括解释性评论,解释了个别数据项分类背后的理由,并提供了应如何收集和报告这些数据项的指导。数据集包括九个所需和六种推荐的元素,用于报告活组织检查和经尿道切除(Tur)标本中的尿路癌。所需的元素包括标本部位,手术程序,组织学肿瘤型,尿路上皮癌的亚型/变异,肿瘤级,侵袭程度,肌肉血栓,非侵入性癌和淋巴血管入侵(LVI)。推荐的元素包括临床信息,块识别键,T1疾病的程度,相关的上皮病变,共存病理和辅助研究。该数据集提供了用于全球协调的结构化模板,用于管理患有患有活组织检查和Tur标本中的泌尿道癌症的患者所需的病理学数据所需的病理数据。预计这将有助于国际合作,减少更新当前国家/体制数据集的重复努力,对尚未制定自己的数据集的国家特别有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号